A detailed history of Wolff Wiese Magana LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Wolff Wiese Magana LLC holds 51 shares of CRNX stock, worth $2,750. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51
Holding current value
$2,750
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$43.83 - $54.98 $2,235 - $2,803
51 New
51 $2,000

Others Institutions Holding CRNX

About Crinetics Pharmaceuticals, Inc.


  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $2.9B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track Wolff Wiese Magana LLC Portfolio

Follow Wolff Wiese Magana LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolff Wiese Magana LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolff Wiese Magana LLC with notifications on news.